- Home
- RXRX vs BATRA Comparison
RXRX vs BATRA Comparison
Compare RXRX & BATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RXRX
- BATRA
- Stock Information
- Founded
- RXRX 2013
- BATRA 1991
- Country
- RXRX United States
- BATRA United States
- Employees
- RXRX N/A
- BATRA N/A
- Industry
- RXRX Biotechnology: Pharmaceutical Preparations
- BATRA Broadcasting
- Sector
- RXRX Health Care
- BATRA Industrials
- Exchange
- RXRX Nasdaq
- BATRA Nasdaq
- Market Cap
- RXRX 2.6B
- BATRA 2.6B
- IPO Year
- RXRX 2021
- BATRA N/A
- Fundamental
- Price
- RXRX $4.33
- BATRA $43.49
- Analyst Decision
- RXRX Buy
- BATRA Strong Buy
- Analyst Count
- RXRX 5
- BATRA 2
- Target Price
- RXRX $7.60
- BATRA $56.50
- AVG Volume (30 Days)
- RXRX 22.1M
- BATRA 47.6K
- Earning Date
- RXRX 05-05-2025
- BATRA 05-12-2025
- Dividend Yield
- RXRX N/A
- BATRA N/A
- EPS Growth
- RXRX N/A
- BATRA N/A
- EPS
- RXRX N/A
- BATRA N/A
- Revenue
- RXRX $59,790,000.00
- BATRA $662,748,000.00
- Revenue This Year
- RXRX $57.30
- BATRA $7.24
- Revenue Next Year
- RXRX $51.53
- BATRA $5.65
- P/E Ratio
- RXRX N/A
- BATRA N/A
- Revenue Growth
- RXRX 29.32
- BATRA 3.45
- 52 Week Low
- RXRX $3.79
- BATRA $38.67
- 52 Week High
- RXRX $12.36
- BATRA $46.65
- Technical
- Relative Strength Index (RSI)
- RXRX 36.37
- BATRA 53.55
- Support Level
- RXRX $4.11
- BATRA $43.21
- Resistance Level
- RXRX $5.90
- BATRA $44.09
- Average True Range (ATR)
- RXRX 0.39
- BATRA 0.75
- MACD
- RXRX -0.11
- BATRA 0.07
- Stochastic Oscillator
- RXRX 11.00
- BATRA 60.98
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
About BATRA Atlanta Braves Holdings Inc. Series A
Atlanta Braves Holdings Inc is a holding company. It operates through its wholly-owned subsidiary, which is the owner and operator of the Atlanta Braves Major League Baseball Club and the mixed-use real estate development, The Battery Atlanta, and is the operator of the Atlanta Braves Major League Baseball Club's stadium, Truist Park. The company predominantly derives revenue related to the Braves baseball franchise and Truist Park from ticket sales, concessions, local broadcasting rights, advertising sponsorships, suites and premium seat fees, retail and licensing revenue, shared MLB revenue streams, including national broadcasting rights and licensing, and other sources. The company's reportable segments include: Baseball which generates key revenue, and Mixed-Use Development.